- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| Mi | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
| Mi | CH BIOTECH SER (08037): INTERIM REPORT 2026 | 1 | HKEx | ||
| CHINA BIOTECH SERVICES Aktie jetzt für 0€ handeln | |||||
| 03.09. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - COOPERATION AGREEMENT IN RELATION TO CROSS-BORDER BNCT CLINICAL SERVICES | 2 | HKEx | ||
| 28.08. | CH BIOTECH SER (08037): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026 | - | HKEx | ||
| 13.08. | CH BIOTECH SER (08037): COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE ... | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): NOTICE OF BOARD MEETING | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): POSITIVE PROFIT ALERT | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - MASTER COLLABORATION AGREEMENT WITH STELLA PHARMA CORPORATION IN RELATION TO COMMERCIALISATION OF BNCT ... | 1 | HKEx | ||
| 07.08. | CH BIOTECH SER (08037): COMPLETION OF DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | 2 | HKEx | ||
| 03.08. | CH BIOTECH SER (08037): COMPANY INFORMATION SHEET | - | HKEx | ||
| 03.08. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - PRESENTATION OF INITIAL FOLLOW-UP FINDINGS OF BORON NEUTRON CAPTURE THERAPY AT THE 22ND CONGRESS ON NEUTRON ... | 2 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND ... | 1 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR ... | - | HKEx | ||
| 26.06. | CH BIOTECH SER (08037): FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE ... | - | HKEx | ||
| 26.06. | CH BIOTECH SER (08037): UPDATES ON DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | - | HKEx | ||
| 16.06. | CH BIOTECH SER (08037): SUPPLEMENTAL ANNOUNCEMENT TO THE UPDATE ON EXEMPTED CONNECTED TRANSACTION IN RELATION TO THE ADOPTION OF SHARE AWARD SCHEME BY ... | - | HKEx | ||
| 15.06. | CH BIOTECH SER (08037): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 JUNE 2026 | - | HKEx |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 77,00 | +0,26 % | DexCom, Inc.: Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care | New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1 New partnership reinforces... ► Artikel lesen | |
| MCKESSON | 796,20 | -0,55 % | McKesson Extends CVS Health Pact To 2032, Reaffirms FY27 Adj. EPS Guidance | WOONSOCKET (dpa-AFX) - Pharmaceutical distributor McKesson Corp. (MCK), announced on Thursday that it has signed an agreement in principle to extend its partnership with CVS Health Corp. (CVS)... ► Artikel lesen | |
| MORE LIFE COMPANY | 0,036 | -0,28 % | XFRA NEW INSTRUMENTS AVAILABLE ON 24.08.2026 | The following instruments on XETRA do have their first trading 24.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.08.2026
Aktien
1 CA0966311064 Boardwalk Real Estate... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,740 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| FRESENIUS | 43,800 | -2,12 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,610 | -0,95 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,680 | +0,28 % | Fresenius Medical Care: China sorgt für eine Millionenbelastung | Fresenius Medical Care stellt sein Geschäft in China neu auf und nimmt dafür eine erhebliche Belastung in Kauf. Der Dialysekonzern rechnet im dritten Quartal 2026 mit Sonderaufwendungen von rund 110... ► Artikel lesen | |
| NEXALIN TECHNOLOGY | 7,550 | 0,00 % | Nexalin Technology, Inc.: Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation | Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync across seven countries and more than 300 million people, with a structured pricing framework... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,430 | 0,00 % | Raymond James startet Coverage für Aveanna Healthcare mit "Strong Buy" | ||
| BRIGHTSPRING HEALTH SERVICES | 57,27 | 0,00 % | BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026 | ||
| PROCEPT BIOROBOTICS | 17,020 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 48,925 | +0,03 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| GENEDX | 71,08 | +0,17 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| GERRESHEIMER | 27,720 | -4,22 % | EQS-AFR: Gerresheimer AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Gerresheimer AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Gerresheimer AG: Vorabbekanntmachung über... ► Artikel lesen | |
| BILLIONTOONE | 105,67 | -0,09 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen |
CHINA BIOTECH SERVICES HOLDINGS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA BIOTECH SERVICES HOLDINGS LTD finden Sie auf Wallstreet Online.